F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Steatosis

Page 1 of 2 ( 86 items )
<<
1
2
>>

1	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 168 \| Download: 398
2	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 179 \| Download: 581
3	Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease 10/27/2025 10:57:53 AM \| Browse: 321 \| Download: 501
4	Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion 4/18/2025 8:22:26 AM \| Browse: 142 \| Download: 474
5	Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease 4/11/2025 2:19:32 AM \| Browse: 260 \| Download: 1096
6	Prospects of elafibranor in treating alcohol-associated liver diseases 12/18/2024 7:36:02 AM \| Browse: 207 \| Download: 687
7	Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective 10/21/2024 7:03:25 AM \| Browse: 201 \| Download: 630
8	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 507 \| Download: 1625
9	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 538 \| Download: 1444
10	Pancreatic fat in type 2 diabetes: Causal or coincidental? 3/1/2023 6:11:27 AM \| Browse: 561 \| Download: 1309
11	Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring 7/4/2022 12:30:52 PM \| Browse: 723 \| Download: 1650
12	Metabolic aspects of hepatitis C virus 6/10/2022 5:40:20 AM \| Browse: 772 \| Download: 1829
13	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 798 \| Download: 1604
14	Glycogen hepatopathy in type-1 diabetes mellitus: A case report 2/22/2022 9:25:38 AM \| Browse: 724 \| Download: 1505
15	Nonalcoholic fatty liver disease shows significant sex dimorphism 2/11/2022 5:55:19 AM \| Browse: 708 \| Download: 1940
16	Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence 1/21/2022 8:16:14 AM \| Browse: 917 \| Download: 1929
17	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 783 \| Download: 1403
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 1011 \| Download: 1754
19	Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study 8/4/2021 7:56:20 AM \| Browse: 845 \| Download: 2206
20	Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion 7/12/2021 12:42:13 AM \| Browse: 987 \| Download: 2141
21	PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease 7/6/2021 2:31:17 AM \| Browse: 903 \| Download: 2577
22	Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis 6/18/2021 5:06:16 AM \| Browse: 935 \| Download: 2086
23	Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients 5/8/2021 7:57:00 AM \| Browse: 937 \| Download: 2095
24	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 1061 \| Download: 1745
25	Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study 2/5/2021 10:20:18 AM \| Browse: 1012 \| Download: 2773
26	Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo 11/24/2020 12:41:21 PM \| Browse: 1030 \| Download: 2394
27	Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis 11/6/2020 7:36:12 AM \| Browse: 1104 \| Download: 2782
28	Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis 9/4/2020 7:25:49 AM \| Browse: 1032 \| Download: 2955
29	Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we 8/7/2019 7:09:17 AM \| Browse: 1329 \| Download: 1929
30	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 1276 \| Download: 1614
31	Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease 6/28/2019 12:22:27 PM \| Browse: 1496 \| Download: 2762
32	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1562 \| Download: 2442
33	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1531 \| Download: 2253
34	Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies 1/21/2019 5:38:30 AM \| Browse: 1453 \| Download: 1942
35	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1640 \| Download: 2386
36	Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1326 \| Download: 2414
37	Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease 9/25/2018 3:44:36 AM \| Browse: 1448 \| Download: 2280
38	Feasibility of using marginal liver grafts in living donor liver transplantation 6/15/2018 9:13:16 AM \| Browse: 1570 \| Download: 2032
39	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction 4/27/2018 3:25:40 AM \| Browse: 1614 \| Download: 2073
40	Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals 3/16/2018 12:27:25 PM \| Browse: 1652 \| Download: 3028
41	circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling 1/19/2018 9:46:49 AM \| Browse: 1468 \| Download: 2446
42	Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease 6/20/2017 12:12:52 PM \| Browse: 1602 \| Download: 2386
43	Non-alcoholic fatty liver disease: An expanded review 6/6/2017 12:54:56 AM \| Browse: 1886 \| Download: 2057
44	Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 5/20/2017 12:26:24 PM \| Browse: 1898 \| Download: 2117
45	Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice 5/16/2017 6:56:36 AM \| Browse: 1824 \| Download: 3207
46	Non-alcoholic fatty liver disease and cardiovascular risk 5/16/2017 6:56:36 AM \| Browse: 1778 \| Download: 1996
47	Changes in human hepatic metabolism in steatosis and cirrhosis 4/20/2017 3:58:56 PM \| Browse: 2014 \| Download: 3266
48	Association between endotoxemia and histological features of nonalcoholic fatty liver disease 1/19/2017 11:16:00 AM \| Browse: 1891 \| Download: 2760
49	Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study 12/27/2016 8:31:00 AM \| Browse: 1934 \| Download: 3485
50	Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 11/26/2016 6:56:00 PM \| Browse: 1825 \| Download: 2404

Page 1 of 2 ( 86 items )
<<
1
2
>>

1	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 168 \| Download: 398
2	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 179 \| Download: 581
3	Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease 10/27/2025 10:57:53 AM \| Browse: 321 \| Download: 501
4	Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion 4/18/2025 8:22:26 AM \| Browse: 142 \| Download: 474
5	Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease 4/11/2025 2:19:32 AM \| Browse: 260 \| Download: 1096
6	Prospects of elafibranor in treating alcohol-associated liver diseases 12/18/2024 7:36:02 AM \| Browse: 207 \| Download: 687
7	Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective 10/21/2024 7:03:25 AM \| Browse: 201 \| Download: 630
8	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 507 \| Download: 1625
9	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 538 \| Download: 1444
10	Pancreatic fat in type 2 diabetes: Causal or coincidental? 3/1/2023 6:11:27 AM \| Browse: 561 \| Download: 1309
11	Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring 7/4/2022 12:30:52 PM \| Browse: 723 \| Download: 1650
12	Metabolic aspects of hepatitis C virus 6/10/2022 5:40:20 AM \| Browse: 772 \| Download: 1829
13	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 798 \| Download: 1604
14	Glycogen hepatopathy in type-1 diabetes mellitus: A case report 2/22/2022 9:25:38 AM \| Browse: 724 \| Download: 1505
15	Nonalcoholic fatty liver disease shows significant sex dimorphism 2/11/2022 5:55:19 AM \| Browse: 708 \| Download: 1940
16	Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence 1/21/2022 8:16:14 AM \| Browse: 917 \| Download: 1929
17	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 783 \| Download: 1403
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 1011 \| Download: 1754
19	Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study 8/4/2021 7:56:20 AM \| Browse: 845 \| Download: 2206
20	Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion 7/12/2021 12:42:13 AM \| Browse: 987 \| Download: 2141
21	PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease 7/6/2021 2:31:17 AM \| Browse: 903 \| Download: 2577
22	Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis 6/18/2021 5:06:16 AM \| Browse: 935 \| Download: 2086
23	Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients 5/8/2021 7:57:00 AM \| Browse: 937 \| Download: 2095
24	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 1061 \| Download: 1745
25	Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study 2/5/2021 10:20:18 AM \| Browse: 1012 \| Download: 2773
26	Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo 11/24/2020 12:41:21 PM \| Browse: 1030 \| Download: 2394
27	Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis 11/6/2020 7:36:12 AM \| Browse: 1104 \| Download: 2782
28	Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis 9/4/2020 7:25:49 AM \| Browse: 1032 \| Download: 2955
29	Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we 8/7/2019 7:09:17 AM \| Browse: 1329 \| Download: 1929
30	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 1276 \| Download: 1614
31	Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease 6/28/2019 12:22:27 PM \| Browse: 1496 \| Download: 2762
32	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1562 \| Download: 2442
33	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1531 \| Download: 2253
34	Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies 1/21/2019 5:38:30 AM \| Browse: 1453 \| Download: 1942
35	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1640 \| Download: 2386
36	Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1326 \| Download: 2414
37	Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease 9/25/2018 3:44:36 AM \| Browse: 1448 \| Download: 2280
38	Feasibility of using marginal liver grafts in living donor liver transplantation 6/15/2018 9:13:16 AM \| Browse: 1570 \| Download: 2032
39	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction 4/27/2018 3:25:40 AM \| Browse: 1614 \| Download: 2073
40	Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals 3/16/2018 12:27:25 PM \| Browse: 1652 \| Download: 3028
41	circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling 1/19/2018 9:46:49 AM \| Browse: 1468 \| Download: 2446
42	Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease 6/20/2017 12:12:52 PM \| Browse: 1602 \| Download: 2386
43	Non-alcoholic fatty liver disease: An expanded review 6/6/2017 12:54:56 AM \| Browse: 1886 \| Download: 2057
44	Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 5/20/2017 12:26:24 PM \| Browse: 1898 \| Download: 2117
45	Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice 5/16/2017 6:56:36 AM \| Browse: 1824 \| Download: 3207
46	Non-alcoholic fatty liver disease and cardiovascular risk 5/16/2017 6:56:36 AM \| Browse: 1778 \| Download: 1996
47	Changes in human hepatic metabolism in steatosis and cirrhosis 4/20/2017 3:58:56 PM \| Browse: 2014 \| Download: 3266
48	Association between endotoxemia and histological features of nonalcoholic fatty liver disease 1/19/2017 11:16:00 AM \| Browse: 1891 \| Download: 2760
49	Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study 12/27/2016 8:31:00 AM \| Browse: 1934 \| Download: 3485
50	Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 11/26/2016 6:56:00 PM \| Browse: 1825 \| Download: 2404